Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: finance – Page 70

In addition to securities fraud and obstruction of justice, James Velissaris has been charged with wire fraud and lying to auditors.

The founder and manager of a $1.7 billion mutual fund that collapsed last year has been charged by federal prosecutors with securities fraud and obstruction of justice for allegedly inflating fund asset values to keep investor money flowing, then falsifying records to conceal the improprieties.

The Infinity Q Diversified Alpha Fund halted investor redemptions in February 2021, roughly seven years after it was co-founded by James Velissaris, 37, its chief investment officer. A government inquiry began, Velissaris stepped down and the mutual fund and a parallel hedge fund he oversaw began liquidating.

It was a rare example of a big mutual fund failure amid a roaring bull market. And the collapse ensnared billionaire investor David Bonderman, co-founder of TPG, a huge private-equity firm that went public this year. The Bonderman Family was a major investor in Infinity Q Capital Management, the investment company overseen by Velissaris, regulatory documents show. Velissaris had worked for the Bonderman family before he co-founded Infinity Q Capital Management.

Read more | >

The Future Of Space Tech & Innovation — Dr. Joel Mozer Ph.D., Director of Science, Technology & Research, United States Space Force.

Dr. Joel Mozer is the Director of Science, Technology, and Research, United States Space Force (https://www.spaceforce.mil/).

With a PhD in Physics, and MS in Atmospheric Science, from University of Arizona, Dr. Mozer serves as the principal scientific advisor to the Commander and is the senior authority for all science and technology matters for an organization of approximately 11,000 space professionals worldwide, and manages a global network of satellite command and control, communications, missile warning and launch facilities. In this role, he interacts with other principals, operational commanders, combatant commands, acquisition, and international communities to address cross-organizational science and technical issues and solutions.

Dr. Mozer represents USSF science and technology on decisions, high-level planning, and policy, building coalitions and alliances throughout the U.S. government, industry, academia, the international community, and other scientific and technology organizations.

Dr. Mozer entered government service in 1992 with the U.S. Air Force. Prior to his current assignment, he was Chief Space Experimentalist of the Air Force Research Laboratory Space Vehicle Directorate. In that role, he was responsible for managing AFRL’s $40 million-per-year investment in research and development related to the development of experimental satellites and payloads and conducted a team of 100 engineers and scientists at Kirtland and Holloman Air Force Bases, New Mexico — all working to develop cost-effective ways to assemble, integrate, test and fly novel spacecraft and systems and demonstrating new concepts for Department of Defense systems and missions. His area of specialization relates to space control and remote sensing — understanding the natural and man-made space environment and developing forecast tools for warfighters, theater battle commanders and other decision-makers to mitigate risks.

Continue reading “Dr Joel Mozer, PhD — United States Space Force — Director of Science, Technology, and Research” | >

Pioneering global generic medicine access to improve and extend people’s lives — keren haruvi snir-president, sandoz US, head of north america.

Keren Haruvi is President of Sandoz US and Head of their North America business (https://www.novartis.us/about-us/our-leadership/us-country-l…n-haruvi).

Sandoz is a division of the Novartis Group and a global leader in generic pharmaceuticals and biosimilars and was established in 2003, when Novartis united all of its generics businesses under the name Sandoz – a single global brand with a long history. Since then, Sandoz has grown into a leading global generics business with annual sales of approximately US$10 billion.

In her current role, Keren leads Sandoz’ largest commercial and country organization – the United States – which is responsible for over 35% of Sandoz global revenue. She also oversees Sandoz commercial operations in Canada. In addition to serving on the Novartis Country Leadership Team, Keren is a member of the Global Sandoz Executive Committee.

Prior to joining Sandoz, Keren served as Global Head of M&A at Novartis International AG. Her early career began at Teva Pharmaceutical Industries where she steadily advanced in leadership roles to Senior VP, Global Business Development and Alliance Management.

Continue reading “Keren Haruvi — President, Sandoz US, Head Of North America — Global Generic Medicine Access For All” | >

Machine learning, a form of artificial intelligence, vastly speeds up computational tasks and enables new technology in areas as broad as speech and image recognition, self-driving cars, stock market trading and medical diagnosis.

Before going to work on a given task, algorithms typically need to be trained on pre-existing data so they can learn to make fast and accurate predictions about future scenarios on their own. But what if the job is a completely new one, with no data available for training?

Now, researchers at the Department of Energy’s SLAC National Accelerator Laboratory have demonstrated that they can use machine learning to optimize the performance of particle accelerators by teaching the algorithms the basic principles behind operations—no prior data needed.

Read more | >

Fed Chair Jerome Powell and his colleagues are moving ahead cautiously and methodically.

The Federal Reserve Bank of Boston is also expected to release the results of its research into the technological challenges associated with implementing a CBDC in the U.S.

It would take five-to-ten years to introduce a digital currency in the U.S., several experts say, but they argue policymakers can’t sit idly by.

Read more | >

In collaboration with a team at the Federal Reserve Bank of Boston, MIT experts have begun designing and testing technical research through which further examination of a Central Bank Digital Currency (CBDC) can be performed in the U.S.

The effort, known as Project Hamilton, is in an exploratory phase, and the research is not intended as a pilot or for public deployment. Instead, the researchers have explored two different approaches that could be used to process transactions, and thus could indicate the technical feasibility of a potential CBDC model. In a process involving significant design flexibility, the MIT group tested factors such as the volume and speed of transactions, and the resilience of the systems in general, among other requirements for a viable digital .

“The core of what we built is a high-speed processor for a centralized digital currency, to demonstrate the throughput, latency, and resilience of a system that could support a payment economy at the scale of the United States,” says Neha Narula, director of MIT’s Digital Currency Initiative and a research scientist at the MIT Media Lab, who led the effort with the Boston Fed. “It is important to note that this project is not a comment on whether or not the U.S. should issue a CBDC—but work like this is vital to help determine the answer to that question. This project serves as a platform for creating and comparing more viable designs, and provides a place to experiment and collaborate on more advanced digital currency functionality.”

Read more | >

Over the years, much has been said about artificial intelligence (AI) and the healthcare industry. Much of it has been focused on two extremes. On one hand, there’s the fairly mature use of neural networks for radiological analysis. On the other, there’s the focus on fraud management. Those have become “must have’s” in my perspective. It’s filling the middle ground that interests me. Medical insurance is, as patients, providers, and payors all can agree, is often convoluted and complex. There’s a business problem in making processes more efficient, and the foolishly named robotic process automation (RPA) is only a step in the right direction. More robust AI can help all three stakeholder groups address their needs in managing medical insurance. The general medical insurance industry does deal with radiology and images. However, that’s typically in specialties. In the dental industry, radiology is a regular tool, using x-rays to understand tooth and gum conditions and then to document work that has been done. The basics of AI and radiology have been covered, in this column and many other places, so this article isn’t going to cover the concepts, it’s important to realize how important that analysis is in dental care.

Full Story:

In this case, it’s increasing the accuracy and speed of dental insurance processing, resulting in better medical control, improved financial outcomes for providers and payors, and improved care and customer service for the patient.

Read more | >

Ben RayfieldWeather control tech exists, to some extent. EMP weapons exist. If there was a 477 mile long lightning, it was probably either due to the sun or is a weapon or a terraforming experiment.

Quinn SenaAuthor.

GIPHY

Genevieve Klien shared a link.

According to a series of etherscan transactions, an attacker has exploited Wormhole, a bridge between the Ethereum and Solana blockchains, for close to $323 million in ETH.

Wormhole is a bridging protocol that enables assets to move across various blockchain protocols. When a user sends assets from one chain to another, the bridge locks the assets and mints a wrapped version of the funds on the destination chain.

Continue reading “3 million in ETH stolen from cross-chain protocol Wormhole” | >

Yanis Varoufakis also discussed “pay-to-earn” and the blockchain’s long-term consequences.

Former Greek Finance Minister and one-time in-house economist at Valve, Yanis Varoufakis, gave a long and freewheeling interview to the website, the Crypto Syllabus, focusing on the blockchain, its potential and disappointments, and where it sits in the larger context of politics, surveillance, and economics.

Of particular note to PC Gamer readers is his description of his time with Valve. Varoufakis had access to Valve’s data on Steam’s nascent player-to-player marketplace in the early 2010s, which he used to advise the company and his own economics research. Describing Valve’s initial pitch to him, Varoufakis said:

Read more | >